Search Browse Earnings

Neumora Therapeutics, Inc.

Nasdaq:NMRA

Biological Products, (No Diagnostic Substances)·WATERTOWN, MA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$135.3M

FY 2024

Net Income

-$130.9M

FY 2024

EPS (Diluted)

-$4.81

FY 2024

Stock Price

$3.26

+7.9%

2026-03-10

52W Range

$0.61 – $3.65

P/E Ratio

-0.7x

Market Cap

$544.7M

Cash

$240.9M

FY 2024

Total Debt

—

Net Cash

$240.9M

Enterprise Value

$303.8M

Debt / EBITDA

1.8x

FY 2024

EV / EBITDA

-2.2x

Employees

—